Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Skipabeat22on May 07, 2021 4:49pm
180 Views
Post# 33156550

RE:RE:We need to see the order from Brazil...

RE:RE:We need to see the order from Brazil...They already have approval for their new product... "The antibody test has received CE mark in Europe and ANVISA regulatory clearance in Brazil."


TheeRook wrote: THRM will need   approval first, by The Brazilian Health Regulatory Agency (ANVISA) to commence marketing, sales and distribution of the  unknown Antibody test.     

Victory Square  was granted approval on Jan. 11, 2021, by The Brazilian Health Regulatory Agency (ANVISA) to commence marketing, sales and distribution for its Safetest 15-minute COVID-19 rapid test assay 

Diomio wrote: For the antigen covid tester... (blood sample) i think next week thrm should release a contract order of millions devices for Brazil and Europe. Glta




<< Previous
Bullboard Posts
Next >>